Davita - Roscommon Dialysis is a medicare approved dialysis facility center in Roscommon, Michigan and it has 13 dialysis stations. It is located in Roscommon county at 10450 N Roscommon Rd, Roscommon, MI, 48653. You can reach out to the office of Davita - Roscommon Dialysis at (989) 275-0362. This dialysis clinic is managed and/or owned by Davita. Davita - Roscommon Dialysis has the following ownership type - Profit. It was first certified by medicare in November, 2015. The medicare id for this facility is 232705 and it accepts patients under medicare ESRD program.
| Name | Davita - Roscommon Dialysis |
|---|---|
| Location | 10450 N Roscommon Rd, Roscommon, Michigan |
| No. of Dialysis Stations | 13 |
| Medicare ID | 232705 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 10450 N Roscommon Rd, Roscommon, Michigan, 48653 | |
| (989) 275-0362 | |
News Archive
Canada is lagging behind many countries in the use of electronic health records and it is critical that the country's medical and political leaders set targets for universal adoption, states an editorial in CMAJ
Metropolitan Health Networks, Inc., a leading provider of healthcare services in Florida, today announced the financial results for their fourth quarter and year ended December 31, 2009.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted orphan drug designation to OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP) for the prevention of death following a potentially lethal dose of total body irradiation during or after a radiation disaster.
"The new state budget in Massachusetts eliminates health care coverage for some 30,000 legal immigrants to help close a growing deficit, reversing progress toward universal coverage just as Congress looks to the state as a model for overhauling the nation's health care system," the New York Times reports.
› Verified 9 days ago
| NPI Number | 1831512003 |
| Organization Name | Roscommon Dialysis |
| Doing Business As | Heideck Dialysis Llc |
| Address | 10450 N Roscommon Rd Roscommon, Michigan, 48653 |
| Phone Number | (989) 275-0362 |
News Archive
Canada is lagging behind many countries in the use of electronic health records and it is critical that the country's medical and political leaders set targets for universal adoption, states an editorial in CMAJ
Metropolitan Health Networks, Inc., a leading provider of healthcare services in Florida, today announced the financial results for their fourth quarter and year ended December 31, 2009.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted orphan drug designation to OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP) for the prevention of death following a potentially lethal dose of total body irradiation during or after a radiation disaster.
"The new state budget in Massachusetts eliminates health care coverage for some 30,000 legal immigrants to help close a growing deficit, reversing progress toward universal coverage just as Congress looks to the state as a model for overhauling the nation's health care system," the New York Times reports.
› Verified 9 days ago
| Dialysis patients with Hemoglobin data | 23 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 39 |
News Archive
Canada is lagging behind many countries in the use of electronic health records and it is critical that the country's medical and political leaders set targets for universal adoption, states an editorial in CMAJ
Metropolitan Health Networks, Inc., a leading provider of healthcare services in Florida, today announced the financial results for their fourth quarter and year ended December 31, 2009.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted orphan drug designation to OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP) for the prevention of death following a potentially lethal dose of total body irradiation during or after a radiation disaster.
"The new state budget in Massachusetts eliminates health care coverage for some 30,000 legal immigrants to help close a growing deficit, reversing progress toward universal coverage just as Congress looks to the state as a model for overhauling the nation's health care system," the New York Times reports.
› Verified 9 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 36 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 291 |
| Percentage of adult patients getting regular hemodialysis at the center | 95 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Canada is lagging behind many countries in the use of electronic health records and it is critical that the country's medical and political leaders set targets for universal adoption, states an editorial in CMAJ
Metropolitan Health Networks, Inc., a leading provider of healthcare services in Florida, today announced the financial results for their fourth quarter and year ended December 31, 2009.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted orphan drug designation to OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP) for the prevention of death following a potentially lethal dose of total body irradiation during or after a radiation disaster.
"The new state budget in Massachusetts eliminates health care coverage for some 30,000 legal immigrants to help close a growing deficit, reversing progress toward universal coverage just as Congress looks to the state as a model for overhauling the nation's health care system," the New York Times reports.
› Verified 9 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita - Roscommon Dialysis with elevated calcium levels.
| Patients with hypercalcemia | 36 |
| Hypercalcemia patient months | 291 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 38 |
| Patients with Serumphosphor less than 3.5 mg/dL | 11 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 33 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 27 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 17 |
| Patients with Serumphosphor greater than 7 mg/dL | 12 |
News Archive
Canada is lagging behind many countries in the use of electronic health records and it is critical that the country's medical and political leaders set targets for universal adoption, states an editorial in CMAJ
Metropolitan Health Networks, Inc., a leading provider of healthcare services in Florida, today announced the financial results for their fourth quarter and year ended December 31, 2009.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted orphan drug designation to OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP) for the prevention of death following a potentially lethal dose of total body irradiation during or after a radiation disaster.
"The new state budget in Massachusetts eliminates health care coverage for some 30,000 legal immigrants to help close a growing deficit, reversing progress toward universal coverage just as Congress looks to the state as a model for overhauling the nation's health care system," the New York Times reports.
› Verified 9 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 47 |
| Patient months included in arterial venous fistula and catheter summaries | 267 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 69 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 12 |
News Archive
Canada is lagging behind many countries in the use of electronic health records and it is critical that the country's medical and political leaders set targets for universal adoption, states an editorial in CMAJ
Metropolitan Health Networks, Inc., a leading provider of healthcare services in Florida, today announced the financial results for their fourth quarter and year ended December 31, 2009.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted orphan drug designation to OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP) for the prevention of death following a potentially lethal dose of total body irradiation during or after a radiation disaster.
"The new state budget in Massachusetts eliminates health care coverage for some 30,000 legal immigrants to help close a growing deficit, reversing progress toward universal coverage just as Congress looks to the state as a model for overhauling the nation's health care system," the New York Times reports.
› Verified 9 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 29 |
| Hospitalization Rate in facility | 232.9 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 469.3 |
| Hospitalization Rate: Lower Confidence Limit | 122.1 |
News Archive
Canada is lagging behind many countries in the use of electronic health records and it is critical that the country's medical and political leaders set targets for universal adoption, states an editorial in CMAJ
Metropolitan Health Networks, Inc., a leading provider of healthcare services in Florida, today announced the financial results for their fourth quarter and year ended December 31, 2009.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted orphan drug designation to OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP) for the prevention of death following a potentially lethal dose of total body irradiation during or after a radiation disaster.
"The new state budget in Massachusetts eliminates health care coverage for some 30,000 legal immigrants to help close a growing deficit, reversing progress toward universal coverage just as Congress looks to the state as a model for overhauling the nation's health care system," the New York Times reports.
› Verified 9 days ago
The rate of readmission show you whether patients who were being treated regularly at Davita - Roscommon Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 16.8 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 31.5 |
| Readmission Rate: Lower Confidence Limit | 7.2 |
News Archive
Canada is lagging behind many countries in the use of electronic health records and it is critical that the country's medical and political leaders set targets for universal adoption, states an editorial in CMAJ
Metropolitan Health Networks, Inc., a leading provider of healthcare services in Florida, today announced the financial results for their fourth quarter and year ended December 31, 2009.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted orphan drug designation to OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP) for the prevention of death following a potentially lethal dose of total body irradiation during or after a radiation disaster.
"The new state budget in Massachusetts eliminates health care coverage for some 30,000 legal immigrants to help close a growing deficit, reversing progress toward universal coverage just as Congress looks to the state as a model for overhauling the nation's health care system," the New York Times reports.
› Verified 9 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Davita - Roscommon Dialysis get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 1.69 (As Expected) |
| SIR: Upper Confidence Limit | 4.59 |
| SIR: Lower Confidence Limit | .43 |
News Archive
Canada is lagging behind many countries in the use of electronic health records and it is critical that the country's medical and political leaders set targets for universal adoption, states an editorial in CMAJ
Metropolitan Health Networks, Inc., a leading provider of healthcare services in Florida, today announced the financial results for their fourth quarter and year ended December 31, 2009.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted orphan drug designation to OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP) for the prevention of death following a potentially lethal dose of total body irradiation during or after a radiation disaster.
"The new state budget in Massachusetts eliminates health care coverage for some 30,000 legal immigrants to help close a growing deficit, reversing progress toward universal coverage just as Congress looks to the state as a model for overhauling the nation's health care system," the New York Times reports.
› Verified 9 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Davita - Roscommon Dialysis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 23 |
| Transfusion Rate in facility | 40 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 194 |
| Transfusion Rate: Lower Confidence Limit | 10 |
News Archive
Canada is lagging behind many countries in the use of electronic health records and it is critical that the country's medical and political leaders set targets for universal adoption, states an editorial in CMAJ
Metropolitan Health Networks, Inc., a leading provider of healthcare services in Florida, today announced the financial results for their fourth quarter and year ended December 31, 2009.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted orphan drug designation to OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP) for the prevention of death following a potentially lethal dose of total body irradiation during or after a radiation disaster.
"The new state budget in Massachusetts eliminates health care coverage for some 30,000 legal immigrants to help close a growing deficit, reversing progress toward universal coverage just as Congress looks to the state as a model for overhauling the nation's health care system," the New York Times reports.
› Verified 9 days ago
The rate of mortality show you whether patients who were being treated regularly at Davita - Roscommon Dialysis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 37 |
| Mortality Rate in facility | 22.1 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 45.5 |
| Mortality Rate: Lower Confidence Limit | 8.9 |
News Archive
Canada is lagging behind many countries in the use of electronic health records and it is critical that the country's medical and political leaders set targets for universal adoption, states an editorial in CMAJ
Metropolitan Health Networks, Inc., a leading provider of healthcare services in Florida, today announced the financial results for their fourth quarter and year ended December 31, 2009.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted orphan drug designation to OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP) for the prevention of death following a potentially lethal dose of total body irradiation during or after a radiation disaster.
"The new state budget in Massachusetts eliminates health care coverage for some 30,000 legal immigrants to help close a growing deficit, reversing progress toward universal coverage just as Congress looks to the state as a model for overhauling the nation's health care system," the New York Times reports.
› Verified 9 days ago
Davita - Roscommon Dialysis Location: 10450 N Roscommon Rd, Roscommon, Michigan, 48653 Phone: (989) 275-0362 |
News Archive
Canada is lagging behind many countries in the use of electronic health records and it is critical that the country's medical and political leaders set targets for universal adoption, states an editorial in CMAJ
Metropolitan Health Networks, Inc., a leading provider of healthcare services in Florida, today announced the financial results for their fourth quarter and year ended December 31, 2009.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted orphan drug designation to OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP) for the prevention of death following a potentially lethal dose of total body irradiation during or after a radiation disaster.
"The new state budget in Massachusetts eliminates health care coverage for some 30,000 legal immigrants to help close a growing deficit, reversing progress toward universal coverage just as Congress looks to the state as a model for overhauling the nation's health care system," the New York Times reports.
› Verified 9 days ago